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Tricho-rhino-phalangeal syndrome (TRPS) is characterized by craniofacial and skeletal abnormalities. Three sub-
types have been described: TRPS I, caused by mutations in the TRPS1 gene on chromosome 8; TRPS II, a micro-
deletion syndrome affecting the TRPS1 and EXT1 genes; and TRPS III, a form with severe brachydactyly, due to
short metacarpals, and severe short stature, but without exostoses. To investigate whether TRPS III is caused by
TRPS1 mutations and to establish a genotype-phenotype correlation in TRPS, we performed extensive mutation
analysis and evaluated the height and degree of brachydactyly in patients with TRPS I or TRPS III. We found 35
different mutations in 44 of 51 unrelated patients. The detection rate (86%) indicates that TRPS1 is the major
locus for TRPS I and TRPS III. We did not find any mutation in the parents of sporadic patients or in apparently
healthy relatives of familial patients, indicating complete penetrance of TRPS1 mutations. Evaluation of skeletal
abnormalities of patients with TRPS1 mutations revealed a wide clinical spectrum. The phenotype was variable in
unrelated, age- and sex-matched patients with identical mutations, as well as in families. Four of the five missense
mutations alter the GATA DNA-binding zinc finger, and six of the seven unrelated patients with these mutations
may be classified as having TRPS III. Our data indicate that TRPS III is at the severe end of the TRPS spectrum
and that it is most often caused by a specific class of mutations in the TRPS1 gene.
Introduction
Three types of tricho-rhino-phalangeal syndrome (TRPS
I [MIM 190350], TRPS II [MIM 150230], and TRPS
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III [MIM 190351]) have been described in the literature.
Features common to all three types are sparse, slowly
growing scalp hair, laterally sparse eyebrows, a bulbous
tip of the nose, and protruding ears. Highly character-
istic are the long flat philtrum and the thin upper ver-
million border. The most typical radiographic findings
* Authors 8–38 are listed alphabetically.
† Present affiliation: Division of Neurology, The Children’s Hospital
of Philadelphia, Philadelphia.
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in TRPS are cone-shaped epiphyses (CSEs), predomi-
nantly at the middle phalanges. Often, they are not de-
tectable before 2 years of age. However, as a first man-
ifestation of future CSEs, mild metaphyseal convexity
can be detected during the first year of life in some cases
(Giedion 1998). CSEs and premature closure of the
growth plates can also be found at other tubular bones,
however, with a much lower incidence (Giedion 1968).
The skeletal age always lags behind the chronological
age until puberty and then typically accelerates. Hip mal-
formations such as coxa plana, coxa magna, or coxa
vara are present in 170% of patients. In older patients,
the hip abnormalities resemble degenerative arthrosis.
Felman and Frias (1977) suspected that TRPS represents
a condition that results from abnormal maturation of
the epiphyses and growth plates, leading to mild to mod-
erate growth retardation.
We have recently identified the TRPS1 gene [MIM
604386, AF178030, AF183810], which maps to 8q24.1
and appears to encode a zinc-finger transcription factor
(Momeni et al. 2000). The deletion of both TRPS1 and
EXT1 leads to TRPS II. Patients have multiple cartilag-
inous exostoses in addition to the findings in TRPS I.
Mental retardation has been described in many patients
with TRPS II as well as in two patients with TRPS I and
a cytogenetically visible deletion in 8q24 (Yamamoto et
al. 1989; Hamers et al. 1990). In contrast, patients with
TRPS I and a submicroscopic deletion or a TRPS1 point
mutation usually have normal intelligence (Brandt et al.
1997; Nardmann et al. 1997; Sasaki et al. 1997; Lu¨decke
et al. 1999).
Sugio and Kajii (1984) and Niikawa and Kamei
(1986) described non–mentally retarded patients with
the typical facial appearance of TRPS I but with more-
severe brachydactyly and growth retardation. None of
the patients had multiple cartilaginous exostoses. Nii-
kawa and Kamei (1986) proposed the diagnosis of
TRPS III for these patients. Since then, a few more pa-
tients with proposed TRPS III have been described (Na-
gai et al. 1994; Itin et al. 1996; Vilain et al. 1999). Kajii
et al. (1994) used metacarpophalangeal pattern profile
(MCPP) analyses in the family described by Sugio and
Kajii (1984) and found that the more severe brachy-
dactyly as compared with individuals with TRPS I was
due to a generalized shortness of all phalanges and met-
acarpals. Furthermore, they found that the shortening
of the tubular bones of the hands was a progressive
process. The skeletal abnormalities such as CSEs or hip
changes in TRPS I are rather variable, which is sup-
ported by the finding that they vary considerably within
families and even between MZ twins with TRPS (Gie-
dion et al. 1973; Naselli et al. 1998; authors’ unpub-
lished observations), whereas the facial appearance of
all patients with TRPSs is rather similar. Thus, it has
been speculated that TRPS III might represent only one
extreme of the clinical spectrum of TRPS I. Here we
describe the genotype-phenotype correlation in a large
number of patients with TRPS I and TRPS III.
Patients and Methods
Patients
This study was approved by the local ethics committee
at the Universita¨tsklinikum Essen. We searched forTRPS1
mutations in 51 unrelated probands with TRPS, including
8 with proposed TRPS III. Thirty probands represent iso-
lated cases and 20 represent familial cases (fig. 1). No
pedigree information was available for patient 10569,
who is an adopted child. In total, we analyzed 79 affected
persons. Both parents of 15 isolated patients and the fa-
ther of 1 additional isolated patient were available for
analysis. In five familial cases (patients 12875, 6492,
13365, 13876, and 13916; table 1), only one affected
individual could be studied. The patients are from Ger-
many (28), Belgium (4), Turkey (4), The Netherlands (3),
Norway (3), Great Britain (2), Japan (2), Austria (1), Can-
ada (1), France (1), Israel (1), and Poland (1).
Mutation Analysis
We isolated high-molecular-weight DNA from the
probands, either from peripheral leukocytes or lympho-
blastoid cell lines, using the NUCLEON II kit (Amer-
sham), and we screened for TRPS1 gene mutations by
direct sequencing of PCR products from genomic DNA,
as described elsewhere (Momeni et al. 2000; Tricho-
Rhino-Phalangeal Syndrome Project). For the detection
of mutations in the patient’s RNA, we isolated total
RNA from either peripheral leukocytes or lymphoblas-
toid cell lines, using the QIAamp RNA Blood or the
RNeasy Mini Kits (Qiagen). For first-strand DNA syn-
thesis, we used random hexamer priming and Avian
Myeloblastosis Virus reverse transcriptase (Gibco BRL;
10 min at room temperature, 15 min at 42C, 5 min at
99C, and 5 min at 5C). We amplified the DNA, using
amplimer primers PM101/PM73 (PM101: 5′-GAAGCT-
CGCGAGTCAAACAT-3′; PM73: 5′-GAGCTGCTCA-
GCCTGAAGT-3′; annealing temperature 56C), which
are located in exon 4 and exon 7 of TRPS1 and are
∼190 kb apart in genomic DNA. They amplify a 1,067-
bp fragment from normal TRPS1 RNA. RT-PCR prod-
ucts were sequenced with primer PM85 (PM85: 5′-GGG-
ATAGTCCCAATGTGGAG-3′; annealing temperature
56C), which is located in exon 5 of TRPS1 and allows
reading through exon 6 into exon 7.
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Figure 1 Pedigrees of familial cases of TRPS. Cases are shown in the order in which they appear in table 1. Affected individuals are
indicated by blackened symbols. Individuals available for sequence analysis are denoted with bars above the symbol.
Anthropometric Analysis
The patients were heterogeneous for sex, age, and eth-
nicity. To compare the heights of the non-Japanese pa-
tients, we calculated the SDs for height with the mean
values for the Western European population (van Wier-
ingen et al. 1971) or the Turkish population (Neyzi et
al. 1973); for the Japanese patients, we took data from
the respective publications (table 1).
MCPP analysis is a graphic method used to depict the
length of the tubular bones of the hand in relation to
one another. It has been used to aid in establishing the
diagnosis of many congenital malformations and bone
dysplasias, including the TRPSs (Poznanski et al. 1974;
Felman and Frias 1977; Kajii et al. 1994; Poznanski and
Gartman 1997). For MCPP analysis, we measured the
lengths of all 19 tubular bones of the hands from the
original hand radiographs of 45 patients, and we cal-
culated the deviation of each bone from the mean for
corresponding age and sex, according to the technique
of Poznanski et al. (1972). The deviations (so-called z¯
scores) are expressed as multiples of SDs. The mean val-
ues and SDs had been established for American-born
individuals of European ancestry by Garn et al. (1972).
The calculations and plots of profiles, the comparison
of the MCPPs from different individuals, and the cal-
culation of Pearson’s correlation coefficient (r) were
done with the computer program ANTRO (release
4.83E; Hosenfeld et al. 1991). In some cases we en-
countered problems with the length measurements be-
cause of bowing of metacarpals and axial deviations at
the interphalangeal joints, which lead to a distorted pro-
jection of the bones on the film.
Neither height data nor hand radiographs were avail-
able for five patients with TRPS1 mutations. Only one
original hand radiograph and one photograph of a hand
X-ray were available from patients in whom we could
not identify a TRPS1 mutation. Skeletal age was deter-
mined according to the tables of Greulich and Pyle (1959).
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Table 1
Summary of TRPS1 Gene Mutations, Height of Patients, and Radiographic Findings
MUTATIONa
CASE IDb INDIVIDUAL SEX MRc AGE
HEIGHT HAND RADIOGRAPHY
Type Location Amino Acid Change in cm SD
dz¯
(Left/Right)
Chronological
Age
Skeletal
Age
Nonsense:
523CrT Exon 3 Q175X 10446* II-1 F  39 y 149.0 2.8 2.5/2.6 32 y Adult
III-2 M  12 y 3 mo 126.0 3.6 2.9/3.0 12 y 4 mo 9 y 3 mo
838delC Exon 3 Stop at codon 322 G1097 F  13 y 157.5 0 NA
1014CrA Exon 4 C338X 68201,* I-2 F  28 y 167.0 0 2.9/3.3 32 y Adult
II-1 M  1 y 1 mo 73.0 1.5 0/NA 1 y 1 mo 6 mo
1031delG Exon 4 Stop at codon 351 5069* ? NA NA
1137–1138insT Exon 4 Stop at codon 380 12875* III-1 F  14 y 9 mo 156.0 1.2 3.6/NA 14 y 9 mo 15 y 1 mo
6492* II-2 M  44 y 167.0 1.6 2.7/2.6 39 y Adult
1413–1426delA-T Exon 4 Stop at codon 477 9801* I-2 F  28 y 161.8 0.7 NA
II-1 F  1 y 8 mo 82.0 0 NA
1469CrG Exon 4 S490X 13927 F / 5 y 6 mo 111.5 0.5 0.4/0.5 5 y 9 mo 3 y
1546GrT Exon 4 E516X 10067 M  11 y 142.0 0.4 NA
1576CrT Exon 4 Q526X 7438* F  NA NA
1591CrT Exon 4 R531X 10569 F / 13 y 9 mo 152.0 1.4 3.0/3.0 11 y 8 mo 9 y 2 mo
13365* I-1 M  25 y 161.0 1.9 3.8/4.4 25 y Adult
14337 M  32 y 169.5 1.2 2.3/1.7 32 y 4 mo Adult
1595–1596delAT Exon 4 Stop at codon 539 9273 F ? 2 y 6 mo 82.3 2.7 NA
1602–1603insA Exon 4 Stop at codon 540 8413 F  8 y 121.0 1.5 1.4/NA 7 y 7 mo 6 y
1831CrT Exon 4 R611X G11162,* I-2 F  42 y 161.0 0.8 NA
II-1 M  18 y 3 mo 169.5/1.2 0.3/NA 7 y 11 mo 6 y 10 mo
II-2 F  15 y 7 mo 159.5 0.8 0.3/NA 5 y 3 mo 2 y 3 mo
II-3 F  13 y 6 mo 162.0 0 1.5/NA 3 y 2 mo 1 y 3 mo
13333* I-2 F  63 y 165.0 0 0.9/1.4 62 y 7 mo Adult
II-2 F  38 y 168.0 0 2.6/2.5 38 y 1 mo Adult
II-4 F  29 y 168.0 0 1.8/1.9 28 y 6 mo Adult
III-1 F  16 y 3 mo 169.0 0 0.8/0.9 16 y 3 mo 17 y
III-3 F  7 y 122.0 0 0.9/ 0.8 7 y 3 y 10 mo
G1353 F  NA NA
13738 F  21 y 146.0 3.3 2.5/2.5 21 y Adult
2047CrT Exon 4 R683X G0985* II-1 F  NA NA
III-1 M  9 y 7 mo 127.0 1.9 NA
III-2 M  7 y 7 mo 126.0 0 NA
2110delA Exon 5 Stop at codon 766 12564 F  26 y 168.0 0 NA
2113–2114delCA Exon 5 Stop at codon 743 13854 F / 5 y 7 mo 104.5 2.0 2.0/2.8 6 y 8 mo 4 y 6 mo
2155CrT Exon 5 Q719X 12736 F ? 3 y 8 mo 88.5 2.4 2.8/NA 3 y 8 mo 1 y 6 mo
2291–2292delTG Exon 5 Stop at codon 788 431 F ? 6 y 6 mo 120.0 0 0.9/0.9 6 y 6 mo 3 y 9 mo
2301–2304delAGAG Exon 5 Stop at codon 791 8230 M  12 y 6 mo 150.0 0 2.2/2.0 12 y 5 mo 9 y 9 mo
2406delG Exon 5 Stop at codon 814 10794 F  10 y 3 mo 131.0 1.6 1.7/NA 10 y 4 mo 8 y 6 mo
2406–2407insG Exon 5 Stop at codon 831 94383,* I-2 F  52 y 155.0 1.8 NA
II-2 F  27 y 157.0 1.5 1.4/NA 23 y Adult
III-1 M  2 y 10 mo 90.0 2.0 1.8/NA 2 y 3 mo 1 y 1 mo
III-2 F  2 y 3 mo 86.5 1.5 2.2/NA 2 y 2 mo 10 mo
2441–2442insT Exon 5 Stop at codon 830 56504 F  16 y 154.0 1.8 NA
2480–2481insT Exon 5 Stop at codon 830 13138* II-2 F  52 y 152.0 2.3 2.7/2.4 51 y 10 mo Adult
III-1 F  26 y 146.0 3.3 NA
III-2 F  22 y 148.0 3.0 2.0/1.9 22 y 2 mo Adult
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2518CrT Exon 5 R840X 12775 F  15 y 159.0 0.8 NA
2534TrA Exon 5 L845X 13876* II-4 F  40 y 152.0 2.3 2.1/2.3 40 y Adult
2816–2817insA Exon 7 Stop at codon 942 13523* II-2 F  39 y 146.0 3.3 1.8/1.5 38 y Adult
III-1 M  17 y 2 mo 166.0 1.5 2.9/2.9 17 y 1 mo 19 y
III-2 M  11 y 3 mo 144.5 0.4 NA
2875CrT Exon 7 Q959X 14338 M  3 y 11 mo 96.5 2.0 2.6/2.4 3 y 10 mo 1 y
3012CrG Exon 7 Y1004X 13164* I-2 F  65 y 162.0 0.7 NA
II-2 M  42 y 168.0 1.4 NA
III-1 M  11 y 7 mo 135.0 1.8 NA
3360–3361insGGAG Exon 7 Stop at codon 1162 110496 M  33 y 176.0 0 NA/3.8 33 y 4 mo Adult
Splice site:
IVS61GrT IVS6 In-frame skipping, exon 6 13568 F  35 y 156.0 1.7 2.0/2.3 35 y 1 mo Adult
Missense:
2681TrA Exon 6 V894D G1298* I-2 F  31 y 156.0 1.7 Originals NA
II-1 M  12 y 6 mo 101.0 7.0 4.8/NA 10 y 11 mo 5 y
2701ArC Exon 6 T901P 132427 M  29 y 147.0 4.6 7.1/NA 17 y 6 mo 14 y 6 mo
2723GrA Exon 6 R908Q 5874 M ? 14 y 6 mo 159.0 0.7 NA
7795 F  15 y 11 mo 150.8 2.4 4.5/4.5 15 y 11 mo 18 y
2723GrC Exon 6 R908P 139168,* II-2 M  35 y 150.0 3.6 Originals NA
2755GrA Exon 6 A919T 13287 F  15 y 10 mo 153.0 2.0 3.6/3.6 16 y 2 mo 16 y 6 mo
13307 F  15 y 152.0 1.1 5.4/5.6 14 y 5 mo 14 y
139159,* I-1 F  28 y 142.5 2.4 See Kajii et al. 1994
II-2 F  8 mo 69.0 0 See Kajii et al. 1994
None identified:
/ 1778 M  17 y 3 mo 151.2 3.7 4.75/NA 17 y 3 mo 17 y
/ 8827 F  11 y 6 mo 146.0 0 Originals NA
/ 10344 F  6 y 6 mo 114.0 1.3 NA
/ 9595 F  13 y 11 mo 152.0 1.4 NA
/ 13243 M  11 y 11 mo 139.0 1.5 NA
/ 8198 F  4 y 101.5 0.7 NA
/ 10510*  NA NA
TRPS1 deletions or
disruptions:
del TRPS1 G138610 M  19 y 166.0 0.7 2.89/2.68 37 y Adult
del TRPS1 518211 F / 10 y 9 mo 129.0 2.1 Originals NA 10 y 3 mo 6 y 3 mo
del TRPS1 1037812 F  11 y 9 mo 155.0 0.5 0.5/0.7 10 y 1 mo 10 y 6 mo
t(7;8;13), del TRPS1 431413 F  14 y 11 mo 162.0 0.3 2.4/2.5 14 y 11 mo 14 y 11 mo
t(8;18)(q24.1;q23) IVS 5 172914 II-1 F  33 y 149.0 2.8 Originals NA
II-2 M  27 y 163.0 2.2 Originals NA
inv(8)(pq) IVS 5 844815 F  4 y 1 mo 91.0 3.2 Originals NA 4 y 1 mo 1 y 6 mo
NOTE. NA p not available; y p years.
a Nucleotide numbers refer to the TRPS1 cDNA sequence; amino acid numbers refer to the deduced peptide sequence. The five recurrent mutations are underlined.
b Patients with designators followed by superscript numbers 1–15 have been described elsewhere, as follows: 1–6Momeni et al. 2000; 7Vilain et al. 1999; 8Nagai et al. 1994; 9Sugio and Kajii 1984; Kajii et al. 1994;
10Hamers et al. 1990; Lu¨decke et al. 1995; 11Nardmann et al. 1997; 12Lu¨decke et al. 1999; 13Brandt et al. 1997; 14Marchau et al. 1993; Lu¨decke et al. 1995; 15Lu¨decke et al. 1999. Asterisks (*) identify familial cases
(see fig.1).
c MR p mental retardation. A minus sign () indicates normal intelligence, two plus signs () indicate severe retardation, and a question mark (?) indicates unknown.
d p mean length deviation of the 19 tubular bones of the left or right hand.z¯
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Figure 2 Structure of the TRPS1 protein and location of mutations. Hatched boxes, zinc-finger motifs (zf). Vertical bars, putative nuclear
localization signals (NLSs). The location of the GATA and IKAROS-like zinc fingers are given. Blackened triangles indicate the localization of
the premature stop codons, and missense mutations are indicated by arrows. The effect of the splice site mutation, skipping of exon 6, is denoted
by an unblackened triangle. Recurrent mutations are identified by an asterisk (*). Note that two different insertion mutations lead to a premature
stop codon at amino acid (aa) 830 and that we found two different missense mutation at aa 908.
The statistical significance of differences of heights of
patients was tested by a one-way analysis of variance
and subsequent two-tailed t test for single groups. Type
1 error was defined as without adjustment for2ap .05
multiple tests.
Results
Spectrum of TRPS1 Mutations
We screened for mutations by sequencing the TRPS1
coding region (exons 3–7) and the flanking intronic se-
quences until a mutation was identified in a particular
patient. In cases of missense mutations, we sequenced
the entire coding region as well as the presumptive non-
coding exon 2 to exclude a further mutation.
We identified mutations in 44 (86%) of 51 patients
with apparently normal chromosomes, in 24 (80%) of
30 patients representing sporadic cases, in 19 (95%) of
20 patients representing familial cases, and in the patient
of unknown origin. We identified 35 different mutations
(table 1) that are evenly distributed throughout the
TRPS1 gene (fig. 2). Five mutations are recurrent, and
four of them were identified in patients of different eth-
nicities. For example, 1591CrT was found in patients
10569 (Norway), 13365 (Turkey), and 14337 (Belgium),
and 2755GrA was found in patients 13287 (Belgium)
and 13307 (Turkey) and in family 13915 (Japan). The
1137-1138insT mutation was found in two families
from Germany. Careful examination of their pedigrees
did not reveal any evidence for a relationship. Six of the
mutations have been described elsewhere (Momeni et al.
2000). We found nine out-of-frame deletions (1–14 bp)
and seven out-of-frame insertions (1–4 bp) in TRPS1.
Although the frameshift mutations may add up to 61
aberrant amino acids (e.g., 2110delA) to the mutant pro-
tein, if the mutant transcripts are not degraded by non-
sense-mediated decay (Frischmeyer and Dietz 1999), we
consider them to be loss-of-function mutations, because
the mutant proteins lack the C-terminal IKAROS-like
zinc-finger motif (Momeni et al. 2000; fig. 2), which is
considered essential for protein-protein interaction. Of
the 19 single-base substitutions, 9 are transversions and
10 are transitions. Six transitions occur in CpG dinu-
cleotides, and four of them are recurrent mutations.
Thirteen single-base substitutions create premature stop
codons.
One base substitution, IVS61GrT (patient 13568),
alters the splice-donor site of intron 6. RT-PCR on RNA
from the patient’s leukocytes with primers PM101 and
PM73 revealed two products: the 1,067-bp (normal)
product and the 944-bp (mutant) product (fig. 3A). Se-
quencing of the RT-PCR product derived from the mu-
tant allele showed that the mutation leads to an in-frame
skipping of the 123-bp exon 6 (fig. 3B).
Five base substitutions cause missense mutations. All
were found in exon 6, which encodes a presumptive
GATA DNA-binding zinc finger. Of interest, we found
only a mutant (2681TrA) but no normal TRPS1 allele
in individual II-1 of family G1298. This was confirmed
by sequencing of the RT-PCR product from the patient’s
leukocyte RNA. This finding is unusual for a dominantly
inherited disease. The patient is also homozygous for
three intragenic single-nucleotide polymorphisms (SNPs;
see below). By dosage-blot analysis with theTRPS1 exon
6 amplimer probe PM65/PM64 and the control probe
YL48E (15q12 [provided by Karin Buiting]), we deter-
mined that the patient has two copies of the mutant
TRPS1 gene (data not shown). We could not clarify
whether the homozygosity is due to a maternal isodi-
somy at 8q24, because the patient’s father is unknown
and no material from his mother was left.
We did not find any mutation in the parents in spo-
radic cases or in apparently healthy relatives in familial
cases. We want to emphasize that the parents of four of
the five sporadic patients with missense mutations (pa-
tients 13242, 7795, 13287, and 13307) were available
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Figure 3 Splice-site mutation in patient 13568. A, Agarose gel with products of RT-PCR of RNA from the patient’s leukocytes. The upper
band (1,067 bp) is derived from the normal transcript and the lower band (944 bp) from the mutant transcript. M p length standard (1 Kb
DNA ladder, Gibco BRL). B, Sequence analysis of the RT-PCR product from the mutant transcript. Exon 5 is spliced to exon 7. One putative
NLS (LRRRRG, in italics) is truncated, and the GATA zinc finger is completely absent in the mutant protein.
for the analysis, and none of them has the respective
base substitutions. This indicates that the substitutions
are true de novo mutations and not polymorphisms.
We found three SNPs in the TRPS1 gene. Two SNPs
are located in the noncoding exon 2. SNP1 is a GrA
transition at position 117, and SNP2 is a T insertion
between nucleotides 47 and 48. SNP3 is located in
intron 5 (IVS529ArC). Five of the seven patients, in
whom we could not find a mutation, are heterozygous
for at least one SNP.
Anthropometric Analysis
Short stature and brachydactyly are common features
of TRPS and are determined by means of simple mea-
surements of height and MCPP analysis. To establish a
genotype-phenotype correlation, we collected data on
height and analyzed the hand radiographs of patients
with TRPS I or TRPS III. The genetic status and the
anthropometric data are summarized in table 1.
Height measurements were available for 76 patients.
We observed great variability in the individual relative
heights, even in unrelated patients with identical mu-
tations, if the height of unaffected relatives was taken
into consideration as well. The relative heights ranged
from 0.5 SD above the mean to 7.0 SD below the mean.
The lowest value was found in individual II-1, case
G1298. The patient is very severely affected, with nearly
absent scalp and body hair and low-set, large, protrud-
ing, and dysmorphic ears. Skeletal anomalies include
scoliosis and pectus carinatum, coxa retrosa, and genu
recurvatum. An X-ray of his right hand at age 10 years
11 mo shows CSEs of all metacarpals; of all proximal,
middle, and distal phalanges; and of the distal radius,
with severe shortness of all tubular bones of this hand.
Skeletal age was severely retarded (∼5 years). Because
the individual is homozygous for the missense mutation
V894D, we excluded him from further calculations. The
average height ( ) of the remaining 75 patients was 1.41z¯
SD below the average height of the respective population
(with the standard deviation for single values).sp 1.15
Although the average values for the seven patients with
a chromosomal abnormality ( SD; )z¯p 1.54 sp 1.38
and the six patients in whom we could not identify a
mutation ( SD; ) are also in thisz¯p 1.43 sp 1.25
range, we did not include them in our calculations, be-
cause effects of other genes cannot be excluded.
Growth retardation in TRPS is considered to occur
postnatally and as a progressive process. This is sup-
ported by our finding that the lengths at birth, available
for 16 patients, were in the normal range (49–54 cm)
even if patients were born to affected parents ( ).np 5
Furthermore, the average relative height of the 28 adult
patients with a TRPS1 mutation was smaller (z¯p 
SD; ) than that of the 34 children (¯1.68 sp 1.29 zp
SD; ).1.16 sp 0.96
Because we had found that most patients suspected
of having TRPS III had missense mutations in theTRPS1
gene, we compared the heights of these patients with the
heights of the patients with nonsense mutations. On av-
erage, the nine patients with heterozygous missense mu-
tations are smaller ( SD; ) than thez¯p 2.06 sp 1.42
53 patients with nonsense mutations ( SD;z¯p 1.28
). The heights of children with missense mu-sp 1.06
tations ( SD; ; ) are compa-z¯p 1.24 sp 0.96 np 5
rable to those with nonsense mutations ( SD;z¯p 1.15
; ). However, when only the adult pa-sp 0.98 np 29
tients with missense ( SD; ; )z¯p 3.01 sp 1.28 np 4
or nonsense ( SD; ; ) muta-z¯p 1.45 sp 1.15 np 24
tions are compared, a statistically significant ( )P ! .05
difference can be seen, although the ranges for patients
with missense mutations (1.7 to4.6 SD) and patients
with nonsense mutations (0 to3.3 SD) overlap. Finally,
comparison of the average height of adult patients with
missense mutations ( SD; ; )z¯p 3.01 sp 1.28 np 4
with the average height of children with missense mu-
tations ( SD; ; ) proves (z¯p 1.24 sp 0.97 np 5 P !
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Figure 4 MCPP analyses in TRPS. A, Spectrum of MCPPs of
patients with different TRPS1 mutations. B, Comparison of mean
pattern profiles (see text). C, MCPPs of mother (individual II-2) and
daughter (III-1) of family 13333 show no significant correlation
( ).rp 0.38
) that growth retardation in TRPS is a progressive.05
process.
The predominant locations of the TRPS-characteristic
CSEs of the Giedion type 12 or the characteristic cone-
shaped deformity at the base of the affected phalanx in
adults are the middle phalanges (Giedion 1968). This
deformity is the result of a premature closure of the
growth plate, which leads to growth retardation. Poz-
nanski et al. (1974) used MCPP analyses in 11 patients
with TRPS I to establish a characteristic pattern profile,
with shortness of the middle phalanges and ulnar met-
acarpals (“mean Poznanski”; Poznanski et al. 1974). Ka-
jii et al. (1994) found a difference between this TRPS
I–pattern profile and the profiles of patients with pro-
posed TRPS III (family 13915 of the present study), but
they concluded that MCPP analysis is only supportive
but not diagnostic of TRPS III. Because these analyses
were done before the TRPS1 gene had been identified,
we have set out to correlate the pattern profiles with the
particular genetic defect in our patients. The original
hand radiographs were available from 45 patients, and
photographs of hand X-rays were available from 9 fur-
ther patients. For MCPP analysis, we used only the orig-
inal hand X-rays of the 44 patients in whom we had
found a TRPS1 mutation, because we wanted to cal-
culate the mean length deviation (mean SD, ) of all 19z¯
tubular bones of a hand as a measure of the severity of
brachydactyly (table 1). The X-rays of the youngest pa-
tient, individual II-1 of family 6820, did not show CSEs,
and MCPP analysis could not disclose brachydactyly.
The MCPPs of the remaining 43 patients disclosed a
spectrum of affected bones, ranging from only two mid-
dle phalanges bilaterally in patient 10378 ( /z¯p 0.05
0.7), with hemizygosity for TRPS1, to nearly uniform
shortness of all 19 bones of both hands, as in patient
13242 ( at age 17 years), in whom TRPS IIIz¯p 7.1
was diagnosed (Vilain et al. 1999). Figure 4A shows
examples of individual pattern profiles. With one ex-
ception (case 13287), we found that patients with a mis-
sense mutation had, on average, shorter metacarpals
than did those with a nonsense or the splice-site muta-
tion. Therefore, we calculated mean pattern profiles for
either the 35 patients with a heterozygous nonsense (and
the splice-site) mutation (“mean TRPS I”; fig. 4B) or the
four patients with a heterozygous missense mutation
(“mean TRPS III”). Mean pattern profiles were calcu-
lated from the left-hand MCPPs, except for patient
11049, for whom only the right-hand X-ray was avail-
able. For reasons explained above, we did not include
patient G1298 (II-1), patients with chromosomal ab-
normalities, or patients with an unknown genetic defect
in this analysis. We compared the mean MCPPs by cal-
culating the product moment correlation (Pearson’s r;
Poznanski et al. 1972) with the mean Poznanski profile
and with each other. The mean TRPS I profile correlates
better with mean Poznanski ( ; ) thanrp 0.68 P ! .01
mean TRPS III does ( ; ), but mean TRPSrp 0.47 P ! .05
I is significantly different from mean TRPS III (rp
). Like the difference between the mean heights of0.27
patients with TRPS I or TRPS III, the difference between
the pattern profiles “mean TRPS I” and “mean TRPS
III” proves that patients with a missense mutation tend
to be more severely affected than patients with nonsense
mutations. However, MCPP analysis cannot be recom-
mended as an unequivocal diagnostic tool in TRPS. For
example, we found nonsymmetrical changes in 3 of 30
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patients (patients 6820 (I-1), 13365, and 13568), for
whom X-rays of both hands were available. In patient
13365 (I-1), who has the recurrent R531X mutation,
the discrepancy between hands was so extreme that the
left-hand MCPP correlated with the mean TRPS I MCPP
( [ ] vs. ; no correlation withrp 0.73 P ! .001 rp 0.37
the mean TRPS III), whereas the right-hand MCPP
would suggest TRPS III ( [ ] vs.rp 0.64 P ! .01 rp
[ ] for TRPS I). Furthermore, we found, for0.5 P ! .05
example, different MCPPs in a mother (individual II-2)
and her daughter (individual III-1) in case 13333 (rp
, no correlation, fig. 4C) and in unrelated female0.38
patients of the same age with identical missense muta-
tions, patients 13287 and 13307 ( ; no corre-rp 0.19
lation; not shown).
Hand X-rays at different chronological ages were
available from six patients (patients 13927, 13738,
13242, 7795, 13287, and 4314). In all cases, MCPP
analysis revealed that the growth retardation of the
bones was a progressive process. This is in agreement
with the comparison of the heights of children and adults
with TRPS.
The X-rays of most children showed a retarded skel-
etal age compared with chronological age, until puberty.
At puberty, an acceleration of the skeletal age in com-
parison with chronological age was noted. Of interest,
the only exception was patient 13242, with TRPS III
(Vilain et al. 1999). At age 17.5 years, the patient’s skel-
etal age corresponded to 14.5 years.
Discussion
The present and previous studies reveal a disease-causing
TRPS1 mutation in 50 (88%) of 57 unrelated cases of
either TRPS I or TRPS III. This indicates that TRPS1 is
the major if not the only locus for TRPS I and TRPS
III. We found five molecular classes of patients with (i)
a TRPS1 gene deletion or disruption (6 cases), (ii) a
nonsense mutation (35 cases), (iii) an in-frame splice
mutation (1 case), (iv) a missense mutation (8 cases), or
(v) no mutation identified (7 cases). However, evaluation
of the clinical features revealed a broad spectrum rather
than distinct clinical classes. The mild mental retardation
of some of the patients cannot be correlated with a par-
ticular TRPS1 mutation, and the severe mental retar-
dation in case G1386 is most probably due to the large
cytogenetically visible deletion (Hamers et al. 1990; Lu¨-
decke et al. 1995).
As outlined above, we consider all frameshift muta-
tions as loss-of-function mutations. If synthesized at all,
only the three mutant proteins in patients 14338,
13164, and 11409 may have the potential to enter the
nucleus, because, in all others, at least one nuclear lo-
calization signal (NLS) is destroyed or absent. This will
be clarified in ongoing experiments. None of the mutant
proteins would contain the C-terminal IKAROS-like
zinc fingers. The double–zinc finger motif of IKAROS
is known to mediate the formation of homo- or het-
erodimers with other IKAROS isoforms (Sun et al.
1996). This dimerization appears to be necessary for
normal function of the IKAROS transcription factor.
The finding of a mutation that ablates only the 160
most–C-terminal amino acids of the TRPS1 protein (pa-
tient 11049) may indicate that homo- or heterodimer-
ization is necessary for the normal function of TRPS1,
as well. Experiments aiming at the identification of po-
tential binding partners for TRPS1 are in progress. As
shown by RT-PCR, the splice mutation in patient 13568
leads to a stable, truncated transcript. The predicted
mutant protein lacks the GATA DNA-binding zinc fin-
ger and has a truncated N-terminal NLS (fig. 3B) and,
thus, probably does not enter the nucleus. The pheno-
type of most patients with a nonsense mutation or the
splice mutation fits into the observed spectrum of TRPS
I and resembles the phenotype of patients with a TRPS1
deletion or disruption. Because the TRPS1 gene seems
to be normally expressed biallelically, we assume that
all nonsense mutations and the splice-site mutation, all
found in a heterozygous state, reduce the dosis of TRPS1
protein by half, as do complete TRPS1 deletions or
TRPS1 disruptions. This supports the hypothesis that
haploinsufficiency at TRPS1 is the major cause of TRPS
I.
All missense mutations identified so far are located
in TRPS1 exon 6, in the GATA zinc-finger domain. The
V894D mutation is located at the N-terminal side of
this domain. It exchanges a neutral with an acidic amino
acid. The phenotype of the index patient (G1298 II-1)
resembles severe TRPS III; however, his mother (indi-
vidual I-2), who is heterozygous for the missense mu-
tation, is typical for TRPS I. Thus, this missense mu-
tation seems to have a mild effect in the heterozygote,
comparable to a nonsense mutation. This is compatible
with the finding that the homozygote is viable. The four
other missense mutations alter the GATA DNA-binding
zinc finger. Patient 13242, with TRPS III (Vilain et al.
1999), is the most severely affected patient in our study,
with a heterozygous missense mutation. He carries a
T901P mutation, which is expected to disrupt the b-
sheet structure of this portion of the zinc finger and to
alter the shape of the entire zinc finger. Patient 13916
II-2, with TRPS III (fig. 1), has an arginine to proline
substitution at position 908 (R908P), which is likely to
disrupt the b-sheet structure at the tip of the zinc finger.
Of interest, we found another missense mutation at po-
sition 908 in two unrelated patients from The Neth-
erlands and Germany. This R908Q mutation changes a
basic to a neutral, polar amino acid at the very tip of
the zinc finger. Patient 5874 is a boy with moderate
mental retardation and without a family history of
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TRPS I. Unfortunately, the original X-rays of his hands
were not available. However, photographs of his hands
showed prominent interphalangeal joints, which is in-
dicative for CSEs. Photographs of his feet showed short
rays 4 and 5, bilaterally. This patient is of nearly normal
height (0.7 SD). Patient 7795 is a 16-year-old girl with
normal intelligence and mild short stature (2.4 SD).
MCPP analysis revealed severe brachydactyly (z¯p 
) with involvement of metacarpals II–V. The A919T4.5
missense mutation exchanges a nonpolar to a polar
amino acid within the Zn2-chelating domain of the zinc
finger, which probably destabilizes the finger structure
by an impairment of Zn2 binding. The A919T muta-
tion was found in a family from Japan (case 13915,
individuals I-1 and II-2) and in two sporadic patients
from Belgium (case 13287) and Turkey (case 13307).
For the Japanese patients, the diagnosis of Ruvalcaba
syndrome had been proposed (Sugio and Kajii 1984)
but was corrected to TRPS III 10 years later (Kajii et
al. 1994). The three elder patients with the A919T mu-
tation have moderate short stature but remarkably short
hands. On average, adult patients with TRPS1 missense
mutations are smaller than those with nonsense muta-
tions but are not as small as patients with the contiguous
gene syndrome TRPS II, in whom the deletion of the
EXT1 gene, which is also involved in bone develop-
ment, exerts an additive effect (average height z¯p 
SD; ; Langer et al. 1984).3.91 np 20
All proteins with missense mutations are expected to
be able to enter the nucleus and form dimers or mul-
timers through the IKAROS-like zinc-finger domains.
These mutants probably have a decreased affinity to
DNA, because of the altered GATA zinc fingers, and
exert a dominant negative effect as a component of a
multimeric protein complex, in contrast to haploinsuf-
ficiency supposed for the remaining mutations. Our data
demonstrate that TRPS has a broad spectrum with re-
gard to growth retardation and brachydactyly. How-
ever, patients with a missense mutation in the GATA
zinc finger tend to be more severely affected, and pa-
tients with the T901P and R908P mutations, which are
supposed to lead to dramatic conformational changes,
define the severe end of the TRPS spectrum.
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